Autoimmunity and idiopathic dilated cardiomyopathy: Where we stand?

References

• Witebsky E, Rose NR, Terplan K, Paine JR, Egan RW. Chronic thyreoiditis and autoimmunization. J Am Med Assoc 1957; 164: 1439–1447
   PubMed Web of Science ®Google Scholar
• Matsui S, Fu M, Katsuda S, Hayase M, Yamaguchi N, Teraoka K, Kurihara T, Takekoshi N, Murakami E, Hoebeke J, Hjalmarson A. Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. J Mol Cell Cardiol 1997; 29(2)641–655
   PubMed Web of Science ®Google Scholar
• Matsui S, Fu M, Hayase M, Katsuda S, Yamaguchi N, Teraoka K, Kurihara T, Takekoshi N. Transfer of rabbit autoimmune cardiomyopathy into severe combined immunodeficiency mice. J Cardiovasc Pharmacol 2003; 42(Suppl 1)S99–S103
   Google Scholar
• Iwata M, Yoshikawa T, Baba A, Anzai T, Nakamura I, Wainai Y, Takahashi T, Ogawa S. Autoimmunity against the second extracellular loop of beta(1)-adrenergic receptors induces beta-adrenergic receptor desensitization and myocardial hypertrophy in vivo. Circ Res 2001; 88(6)578–586
   PubMed Web of Science ®Google Scholar
• Omerovic E, Bollano E, Andersson B, Kujacic V, Schulze W, Hjalmarson A, Waagstein F, Fu M. Induction of cardiomyopathy in severe combined immunodeficiency mice by transfer of lymphocytes from patients with idiopathic dilated cardiomyopathy. Autoimmunity 2000; 32(4)271–280
   PubMed Web of Science ®Google Scholar
• Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, Lohse MJ. Direct evidence for a beta1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 2004; 113(10)1419–1429
   PubMed Web of Science ®Google Scholar
• Chen J, Larsson L, Haugen E, Fedorkova O, Angwald E, Waagstein F, Fu M. Effects of autoantibodies removed by immunoadsorption from patients with dilated cardiomyopathy on neonatal rat cardiomyocytes. Eur J Heart Fail 2006; 8(5)460–467
   PubMed Web of Science ®Google Scholar
• Buvall L, Tang MS, Isic A, Andersson B, Fu M. Antibodies against the beta(1)-adrenergic receptor induce progressive development of cardiomyopathy. J Mol Cell Cardiol 2007; 42(5)1001–1007
   PubMed Web of Science ®Google Scholar
• Buvall L, Bollano E, Chen J, Shultze W, Fu M. Phenotype of early cardiomyopathic changes induced by active immunization of rats with a synthetic peptide corresponding to the second extracellular loop of the human beta-adrenergic receptor. Clin Exp Immunol 2006; 143(2)209–215
   PubMed Web of Science ®Google Scholar
• Störk S, Boivin V, Horf R, Hein L, Lohse MJ, Angermann CE, Jahns R. Stimulating autoantibodies against the cardiac β1-adrenoceptor predict increased mortality in dilated cardiomyopathy. Am Heart J 2006; 152(4)697–704
   PubMed Web of Science ®Google Scholar
• Iwata M, Yoshikawa T, Baba A, Anzai T, Mitamura H, Ogawa S. Autoantibodies against the second extracellular loop of β1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2001; 37: 418–424
   PubMed Web of Science ®Google Scholar
• Caforio AL, Mahon NG, Baig MK, Tona F, Murphy RT, Elliott PM, McKenna WJ. Prospective familial assessment in dilated cardiomyopathy: Cardiac autoantibodies predict disease development in asymptomatic relatives. Circulation 2007; 115(1)76–83
   PubMed Web of Science ®Google Scholar
• Staudt A, Eichler P, Trimpert C, Felix SB, Greinacher A. Fc (gamma) receptors Iia on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy. J Am Coll Cardiol 2007; 49(16)1684–1692
   PubMed Web of Science ®Google Scholar
• Dörffel WV, Felix SB, Wallukat G, Brehme S, Bestvater K, Hofmann T, Kleber FX, Baumann G. Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation 1997; 95: 1994–1997
   PubMed Web of Science ®Google Scholar
• Felix SB, Staudt A, Dörffel WV, Stangl V, Merkel K, Pohl M, Döcke WD, Morgera S, Neumayer HM, Wernecke K-D, Wallukat G, Stangl K, Baumann G. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: Three-month results from a randomized study. J Am Coll Cardiol 2000; 35: 1590–1598
   PubMed Web of Science ®Google Scholar
• Müller J, Wallukat G, Dandel M, Bieda H, Brandes K, Spiegelsberger S, Nissen E, Kunze R, Hetzer R. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 2000; 101: 385–391
   PubMed Web of Science ®Google Scholar
• Staudt A, Schaper F, Stangl V, Plagemann A, Böhm M, Merkel K, Wallukat G, Wernecke K-D, Stangl K, Baumann G, Felix SB. Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 2001; 103: 2681–2686
   PubMed Web of Science ®Google Scholar
• Staudt A, Hummel A, Ruppert J, Dorr M, Trimpert C, Birkenmeier K, Krieg T, Staudt Y, Felix SB. Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study. Am Heart J. 2006; 152(4)712e1–712e6
   Web of Science ®Google Scholar
• Wallukat G, Müller J, Hetzer R. Specific removal of beta1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy. N Engl J Med 2002; 347: 1806
   PubMed Web of Science ®Google Scholar
• Matsui S, Larsson L, Hayase M, Katsuda S, Teraoka K, Kurihara T, Murano H, Nishikawa K, Fu M. Specific removal of beta1-adrenoceptor autoantibodies by immunoabsorption in rabbits with autoimmune cardiomyopathy improved cardiac structure and function. J Mol Cell Cardiol 2006; 41(1)78–85, and other contributions included in this focused issue
   PubMed Web of Science ®Google Scholar